Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single-site, Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects.

Trial Profile

A Single-site, Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2018

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Parkinson's disease; Restless legs syndrome
  • Focus Pharmacokinetics
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 01 Jul 2018 Results assessing PK, safety and tolerability from NCT01675024 and NCT02070796 trials published in the Clinical Therapeutics
    • 04 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top